Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Leukemia. 2010 Apr 1;24(5):976–985. doi: 10.1038/leu.2010.53

Figure 1. Plasma SDF-1 level does not correlate with mobilization efficiency of HSPCs.

Figure 1

Panel A - SDF-1 concentrations are low (less than 1 ng/ml) and do not differ significantly in the plasma of patients who are poor (n=7 or good (n=9) G-CSF mobilizers Panel B - As in patients, SDF-1 concentration is murine plasma is also low (less than 2 ng/ml) and does not increase significantly during Zymosan- or G-CSF-induced mobilization. Panel C – SDF-1 at a physiological concentration does not show chemotactic activity against murine BM HSPCs. The data shown in Panels B and C represent the combined results from three independent experiments carried out in triplicate per group (n=9). * p<0.05, ** p<0.01